Myriad Genetics Inc (NQ: MYGN )

12.37 USD -0.56 (-4.33%)

Streaming Delayed Price Updated: 10:38 AM EDT, Sep 21, 2020 Add to My Watchlist

Price and Volume

Volume	69,937
Open	12.68
Bid (Size)	12.36 (3)
Ask (Size)	12.38 (5)
Prev. Close	12.93
Today's Range	12.24 - 12.81
52wk Range	9.240 - 35.29
Shares Outstanding	69,906,818
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Myriad Genetics Expands Board of Directors with New Member

September 10, 2020

Rashmi Kumar Elected to Myriad’s Board of Directors

American Society of Clinical Oncology Exclusively Cites myChoice® CDx in New Recommendations for Patients with Advanced Ovarian Cancer

August 21, 2020

Performance

YTD	-54.77%	-54.77%
1 Month	-14.51%	-14.51%
3 Month	-0.88%	-0.88%
6 Month	-0.08%	-0.08%
1 Year	-55.50%	-55.50%

More News

Myriad Genetics Announces Inducement Awards

August 14, 2020

Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors

August 13, 2020

Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results

August 13, 2020

New Study Shows Screening Based on Self-Reported Ethnicity Fails to Identify Significant Percentage of Pregnancies Affected by Serious Genetic Conditions

August 10, 2020

Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020

August 06, 2020

Medicare Expands Coverage for BRACAnalysis® CDx in Prostate Cancer

July 31, 2020

Insider Sells Myriad Genetics Stock

September 16, 2020

Expected Growth in Cancer Cases Reinforces Need for Superior Diagnostic Options

July 30, 2020

Myriad Launches Proprietary AMPLIFY™ Technology, Further Increasing the Performance of its Prequel™ NIPS Test

July 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.